Search results
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance· 2 hours agoTherefore, you should definitely take a look at this FREE report showing analyst forecasts for ...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 8 hours agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent...with ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 5 days agoSome of this momentum can be traced to fears of new infectious disease outbreaks, which may...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks· 5 days agoFree Report) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the preceding day's closing price. Coming into today, shares of the biotechnology company had gained ...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 6 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider this: The...
Gateway - Quartz
Quartz· 3 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial. The pharma < ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 5 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna stock is lone omen of bird flu pandemic
Reuters· 5 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 2 days agoOn Thursday, Argus increased its price target on Moderna (NASDAQ:MRNA) shares listed on NASDAQ:MRNA...